CDT Equity Inc. (CDT) vs Oragenics, Inc. (OGEN)

CDT Equity Inc. and Oragenics, Inc. are both Biotechnology companies. CDT Equity Inc. and Oragenics, Inc. are of similar size ($2.4M and $2.3M). CDT Equity Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Across the 8 metrics below, CDT Equity Inc. leads on 5 and Oragenics, Inc. on 3.

Valuation

Metric CDT OGEN Biotechnology median
P/E n/m 0.44 7.88
P/S n/m 17.54 11.47
P/B n/m 0.59 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.16 0.74
EV/Sales n/m (13.16) 10.73
Earnings yield 167,728,033.38% 228.10% (28.84%)
Free cash flow yield (278,822.70%) (469.27%) (23.03%)

Profitability

Metric CDT OGEN Biotechnology median
Gross margin — 19.89% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.68%) (1,307.07%) (57.72%)
Return on assets (55.16%) (264.23%) (49.22%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT OGEN Biotechnology median
Revenue growth (TTM) — (75.08%) 5.64%
EPS growth (last fiscal year) 98.09% 90.51% —
Revenue growth, 5-year CAGR — (50.98%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT OGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.13 3.01 4.73
Net debt to EBITDA 0.05 0.98 0.96

Dividend

Metric CDT OGEN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CDT OGEN Biotechnology median
Market cap 2.41m 2.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack